Another study suggests that EGF receptor‐mediated prostate tumour progression is dependent on STAT3, which regulates the expression of VASP (motility‐limiting vasodilator‐stimulated phosphoprotein), and the apoptosis nexus CASP3. The gene discussed is CASP3; the disease is prostate neoplasm.